Dyadic presents C1 platform data showing vaccine antigen production in about 15 days
DYAI•Dyadic International said it produced purified Bundibugyo Ebola antigens in about 15 days using its C1 platform, with CHO-comparable yield and purity. Antibody production reached about 12-13 grams per liter in seven days.
1. C1 platform results
Dyadic International presented data showing purified Bundibugyo Ebola antigens produced in approximately 15 days from plasmid receipt. The antigens achieved CHO-comparable yield and purity, and structural analysis supported a native-like trimer conformation for MT1001.
2. Manufacturing details
The company said the platform requires no mammalian viral clearance, potentially simplifying manufacturing and reducing costs. DYAI-100 established a clinical manufacturing precedent under cGMP, and its Phase 1 trial met the primary safety endpoint at both dose levels. Antibody production reached approximately 12-13 grams per liter in seven days using human-like G2/G1 glycans.




